U.S. Oil and Gas Stock News

This article looks at whether Ollie's Bargain Outlet Holdings, trading at around US$91, still offers reasonable value or whether the more accessible opportunities may already have passed, and explains the key points in straightforward terms. The stock has pulled back recently, with a 9.6% decline over the last 7 days, a 15.1% decline over the last 30 days, and an 18.2% decline year to date. Over a longer horizon, the 3 year return sits at 60.6% and the 5 year return at 4.6%. Recent...

Globus Medical (NYSE:GMED) has announced that board director John A. DeFord is stepping down from its Board of Directors with immediate effect. DeFord served on the board during key corporate events, including the NuVasive merger, making this governance change a fresh development for shareholders to assess. Globus Medical, trading at $87.35 as of the last close, has seen its share price move 17.5% over the past year and 63.4% over the past 3 years. Recent attention around NYSE:GMED has...

If you are wondering whether Thermo Fisher Scientific at around US$490 per share is pricing in too much optimism or not enough, this article breaks down what that current price tag might really mean for you. The stock has moved 5.6% over the last 7 days, while returns sit at a 5.0% decline over 30 days, a 17.2% decline year to date and a 4.1% decline over the past year, with a 10.8% decline over 3 years and a 9.0% gain over 5 years. Recent headlines around Thermo Fisher Scientific have...

Why Park Hotels & Resorts is on investors’ radar Park Hotels & Resorts (PK) has drawn fresh attention after its latest annual figures showed revenue of US$2,545.0 million alongside a net income loss of US$283.0 million, prompting investors to reassess this lodging REIT. See our latest analysis for Park Hotels & Resorts. At a share price of US$10.60, Park Hotels & Resorts has seen short-term pressure, with a 1-month share price return of a 4.5% decline, even though the 3-year total shareholder...

Wondering whether Babcock & Wilcox Enterprises at US$15.63 is offering value or just headlines? This article breaks down what the current share price might really imply. The stock has seen sharp recent moves, with returns of 10.3% over 7 days, 79.9% over 30 days and 146.1% year to date, while the 1-year return is very large off its prior level. Recent news coverage has focused on Babcock & Wilcox Enterprises as part of broader discussions around capital goods and energy related...

TransMedics Group expanded its National Organ Care System Program, aiming to handle a larger share of U.S. transplant procedures. The company is advancing kidney and lung transplant initiatives, including full control of the ENHANCE clinical trial. TransMedics is preparing simultaneous U.S. and Europe clinical trial launches for its kidney program as part of a broader transplant platform push. TransMedics Group, NasdaqGM:TMDX, is pushing beyond its medical device roots toward a more...

AngloGold Ashanti (NYSE:AU) has released a Technical Report Summary for its Arthur Gold Project in Nevada. The report identifies Arthur as a Tier One gold deposit. New Probable Mineral Reserves have been established for the project. AngloGold Ashanti plans to progress Arthur towards a full feasibility study following this report. For investors following gold producers, AngloGold Ashanti is a large, diversified miner with assets across several regions, and Arthur adds another project in a...

Wondering if California Water Service Group at around US$43.94 is offering fair value right now, or if the price is out of line with what you are actually getting. The stock is up 1.5% over the last 7 days and 2.3% year to date, but it has seen a 5.3% decline over 30 days and a 2.7% decline over the past year, which can change how the market is weighing risk and return. Recent coverage has focused on how regulated utilities like California Water Service Group respond to changing funding...

Earlier in March 2026, Forgent Power Solutions, Inc. filed a follow-on offering of 30,000,000 shares of its Class A common stock and reported second-quarter fiscal 2026 results showing sales of US$296.4 million with net income of US$0.246 million. The company also issued revenue guidance for the second half and full fiscal year 2026 and drew strong media attention for its role supplying electrical distribution equipment for AI data centers, putting both its capital-raising and growth...

Lumen Technologies (NYSE:LUMN) has been named to Fast Company's 2026 list of the World’s Most Innovative Companies in the Enterprise category. This is Lumen’s first appearance on the list and reflects external recognition of its efforts in digital network services. Lumen Technologies enters this recognition period with its shares at $6.97 and a mixed recent track record, including a 6.2% gain over the past week and a 6.4% decline over the past 30 days. Over longer periods, the stock shows a...

Wondering whether TriNet Group's share price reflects its true worth, or if the market is mispricing the stock right now. TriNet Group recently closed at US$36.99, with a 9.3% gain over the last 30 days, but returns of a 1% decline over 7 days and a 52.5% decline over the past year put those moves in a wider context. These price moves come as investors reassess the stock in light of broader company and sector developments, with sentiment shifting over recent months. While the share price...

Permian Basin Royalty Trust (NYSE:PBT) has announced a dividend decrease. The change affects upcoming distributions to unitholders and updates the trust's income profile. Permian Basin Royalty Trust holds royalty interests in oil and gas properties, so its cash distributions are closely tied to production volumes and commodity prices. A dividend adjustment like this can signal that recent cash receipts from underlying properties differ from prior periods. For income focused investors, the...

If you are wondering whether MetLife's current share price reflects its underlying worth, the recent moves in the stock give you plenty to think about. The shares last closed at US$70.39, with a 2.6% gain over the past week, a 6.4% decline over 30 days, and returns of 12.4% decline year to date and 13.6% decline over the last year, set against gains of 36.7% and 34.8% over 3 and 5 years respectively. Recent headlines around MetLife have focused on the business as a large US insurer,...

Cadence Design Systems (NasdaqGS:CDNS) has appointed Dr. Alok Jain as Managing Director for India. The appointment positions India as a key innovation and R&D hub for the company’s semiconductor and design software efforts. Dr. Jain is expected to focus on relationships across government, academia, and industry within India’s growing chip ecosystem. Cadence Design Systems, a major player in electronic design automation and semiconductor IP, is putting more executive weight behind India as a...

Valero Energy (NYSE:VLO) is facing a worker lawsuit that alleges negligence after the recent explosion at its Port Arthur refinery. The suit claims gross negligence related to safety practices and working conditions at one of Valero's largest facilities. This legal action adds fresh scrutiny to the company's operational risk management and potential liability exposure. Valero is one of the largest independent refiners in the US, with operations that supply transportation fuels and other...

If you are wondering whether BioCryst Pharmaceuticals at US$9.40 still offers value, it helps to start by lining up the recent share performance with what the fundamentals suggest the stock might be worth. Over the short term, the share price return sits at 2.6% over 7 days, 24.0% over 30 days and 25.3% year to date, with a 20.5% return over 1 year and 9.8% over 3 years, compared with a 5 year return of a 7.6% decline. These moves are occurring as investors continue to respond to ongoing...

Over the last 7 days, the United States market has remained flat, yet it has risen by 16% over the past year with expectations of earnings growing annually by a similar rate in the coming years. In this context of steady growth, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and potential to outperform these promising market conditions.

In the last week, the United States market has stayed flat, although it is up 16% over the past year with earnings forecasted to grow by 16% annually. In this environment, identifying stocks trading below their estimated intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.

If you are wondering whether Pitney Bowes at around US$10.91 is still offering value or if the easy part of the move is behind it, the starting point is understanding how its current price lines up with different valuation checks. The stock has posted returns of 11.3% over the last 7 days, 5.1% over the past month, 5.6% year to date and 18.6% over the last year, while the 3 year return is very large and the 5 year return sits at 61.5%. Recent headlines have focused on Pitney Bowes in the...

If you are wondering whether Redwire's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. Redwire's share price closed at US$9.16 recently, with a 12.8% return over the last 30 days, a 1.4% return year to date, and a 17.1% decline over the past year, while the 3-year return sits at a very large gain. Recent coverage has focused on Redwire within the Aerospace and Defense space, with attention on how the business is...

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings forecasted to grow at a similar rate annually. In this context of steady growth, stocks with strong insider ownership can be particularly appealing as they often indicate confidence in a company's future prospects and alignment between management and shareholders.

Central Bancompany (CBC) has just been added to a wide range of Russell value and broad market indexes, an inclusion that often shifts how institutional investors and index funds look at the stock. See our latest analysis for Central Bancompany. At a share price of US$23.72, Central Bancompany has seen modest short term softness, with a 30 day share price return of a 2.43% decline. However, the 1 year total shareholder return of 73.02% and 5 year total shareholder return of 134.52% point to...

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings projected to grow annually at a similar rate. In light of these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors seeking opportunities. Penny stocks may be an outdated term, yet they represent a valuable investment area for those interested in smaller or newer companies that offer affordability and potential upside when backed by...

In the last week, the United States market has remained flat, though it has risen by 16% over the past year with earnings expected to grow annually at the same rate. In this environment, identifying stocks with strong fundamentals and growth potential can offer investors opportunities to uncover hidden treasures in a dynamic market landscape.